drugset
drugset / Trial / NCT03044119

The Effect of Platelet Rich Fibrin Matrix With and Without Peripheral Blood Mesenchymal Stem Cells on Implant Stability

NCT03044119 ↗

Phase 1 Unknown 15 enrolled KLE Society's Institute of Dental Sciences
RandomizedParallel-groupTriple-blindTreatment

Summary

The Primary Objectives of the present study are : * To Evaluate the effect of platelet rich fibrin matrix (PRFM) and peripheral blood mesenchymal stem cells (PBMSCs) on implant stability. * To Compare the effect of platelet rich fibrin matrix (PRFM) alone to peripheral blood mesenchymal stem cells (PBMSCs) embedded in platelet rich fibrin matrix (PRFM) on implant stability.

Timeline

Start
2018-03-15
Primary completion
2019-07-20
Completion
2019-10-20

Drugs

EvaluationDrugModalityDoseRoute
Subject PBMSCs Cell therapy — —
Comparator platelet rich fibrin matrix Unknown — —

Indications

No indication recorded.